The FDA and the Next Wave of Drug Abuse — Proactive Pharmacovigilance
Open accessThe DOI matches its Crossref record.
Abstract
The FDA and the Next Wave of Drug Abuse In responding to the opioid crisis, the FDA needs to recognize shifting trends in the addiction landscape. Taking a systematic approach to monitoring such trends should allow the agency to intervene promptly and appropriately to protect the public from associated risks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 5
- 10.1001/jamainternmed.2017.7856 · DOI · Paper page
- 10.1038/nrd.2018.42 · DOI
- 10.1056/NEJMp1704633 · DOI · Paper page
- 10.15585/mmwr.mm6529a4 · DOI
- 10.1016/j.drugalcdep.2012.11.003 · DOI
Cited by
Verret, M., Lauzier, F., Zarychanski, R., Perron, C., Savard, X., Pinard, A.-M., Leblanc, G., Cossi, M.-J., Neveu, X., Turgeon, A. F., et al. (2020) · Anesthesiology · doi:10.1097/aln.0000000000003428 · Cited by 457
Schifano, F., Chiappini, S., Corkery, J. M., & Guirguis, A. (2019) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyz007 · Cited by 194
“A proactive pharmacovigilance may help monitor and anticipate changes in drug abuse, using elements of clinical, epidemiological, basic science, and social science expertise to increase clinicians’ awareness of drug safety issues (Throckmorton et al., 2018).”
Schifano, F., Chiappini, S., Corkery, J. M., & Guirguis, A. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00046 · Cited by 55
Roussin, A., Soeiro, T., Fouque, C., Jouanjus, E., Frauger, E., Fouilhé, N., Mallaret, M., Micallef, J., Lapeyre‐Mestre, M., & the French Addictovigilance Network (FAN) (2022) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15323 · Cited by 38
“The leading role of multimodal, proactive vigilance with complementary tools to investigate high-risk substance use has been highlighted recently for post-marketing surveillance and proved its usefulness for rapid and adapted public health responses in some countries, such as the US.14,64,65 The results of tramadol ad…”
Background
Metadata
- Authors
- Throckmorton, D. C., Gottlieb, S., & Woodcock, J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2018-07-19
- Volume
- 379
- Issue
- 3
- Pages
- 205-207
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2806504163
- Cited by
- 74
- References
- 0
- FWCI
- 11.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The FDA and the Next Wave of Drug Abuse — Proactive Pharmacovigilance. https://app.cochat.ai/papers/10.1056/nejmp1806486
- The paper
- Throckmorton, D. C., Gottlieb, S., & Woodcock, J. (2018). The FDA and the Next Wave of Drug Abuse — Proactive Pharmacovigilance. New England Journal of Medicine. https://doi.org/10.1056/nejmp1806486
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.